See also this year's filing and all EDGAR filings for this company.
PDF Report 0001388320_2025_Actinium_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001388320, Actinium Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 74,506,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 364,000 |
| 3 | remainder_Assets | 2,029,000 |
| 4 | LiabilitiesCurrent | 8,148,000 |
| 5 | LiabilitiesNoncurrent | 35,984,000 |
| 6 | remainder_Liabilities | 9,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,870,431 |
| 9 | ResearchAndDevelopmentExpense | 30,838,607 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | -2,041 |
| 12 | remainder_NetIncome | 3,875,075 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 76,899,000 |
| 1 | Liabilities | 44,141,000 |
| 2 | Expenses | 42,709,038 |
| 3 | Revenues | -2,041 |
| 4 | StockholdersEquity | 32,758,000 |
| 5 | NetIncome | -38,836,004 |
| 6 | ComprehensiveNetIncome | -38,836,004 |
| 7 | BaseVar | 83,813,077 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.538 |
| 9 | EconomicCapitalRatio | 1.92 |
Edgar->Model Mapping
Feature Distribution
Change over Time
